A review, with 9 references, describing the pharmacokinetics and pharmacodynamics of the propafenone analog diprafenone, a sodium channel antagonist with β-blocking properties.It is local anesthetic and combined class Ic and class II antiarrhythmic activities.

01 Feb 1997·Die Pharmazie

Enantioselective determination of diprafenone in human plasma.

Article

Author: Zhong, D ; Fieger-Büschges, H ; Chen, R ; Blume, H

A sensitive (10.0 ng/ml) and stereoselective HPLC method for analysis of S(-)- and R(+)-diprafenone in human plasma has been developed. The assay is based on derivatization with homochiral R(-)-1-(1-naphthyl)ethyl isocyanate to give the diastereomeric derivates and their separation and quantitation using HPLC with UV-detection (220 nm). Details of this stereoselective assay procedure which has already been applied to the multisample analyses from a human pharmacokinetic study are described. The data obtained indicated that the stereoselective disposition of diprafenone enantiomers is quite different from their structural and pharmacological analog propafenone.

03 Jun 1996·European Journal of Clinical PharmacologyQ3 · MEDICINE

Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone - a novel antiarrhythmic agent

Q3 · MEDICINE

Article

Author: R.-G. Alken ; R. Koytchev ; I. Smith ; M. Greenwood ; O. Mayer

OBJECTIVEThe present study was done to investigate the effect of food on the bioavailability of diprafenone.METHODSThe most important pharmacokinetic parameters (Cmax, t1/2, AUC) and the relative oral availability of a solid oral preparation of racemic diprafenone were investigated when administered to fasting subjects and 10 min after a standard meal, in an open, randomised, crossover trial. Single oral doses of 100 mg were given on two different occasions, at least 1 week apart. The serum concentrations of diprafenone and its hydroxy-metabolite were determined up to 24 hours after administration by a sensitive, specific HPLC method. Fifteen healthy, male volunteers were enrolled in the trial. Their mean height, weight and age were 183 cm, 80 kg and 22 years, respectively. Fourteen volunteers were found to be rapid hydroxylators and one was a slow hydroxylator of debrisoquine. Only data from the rapid hydroxylators were used in the statistical analysis.RESULTSFood increased the oral bioavailability of diprafenone by approximately 50%. This effect was similar in rapid and in slow hydroxylators. The only slow hydroxylator in this trial had an AUCzero-last ratio (with food/fasting) of 1.54. These findings suggest that diprafenone should be administered in a constant temporal relationship to food.

100 Deals associated with Diprafenone

External Link

KEGG	Wiki	ATC	Drug Bank
-	Diprafenone	-	-

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Ventricular Arrhythmia	Phase 3	-	Bayer AG	-
Ventricular Arrhythmia	Phase 3	-	Astellas Pharma, Inc.	-
Ventricular Arrhythmia	Phase 3	-	Helopharm W. Petrik GmbH & Co. KG	-
Ventricular Arrhythmia	Phase 3	-	C.H. Boehringer Sohn AG & Co. KG	-

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis